{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:04:14Z","timestamp":1789517054971,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,5]],"date-time":"2027-03-05T00:00:00Z","timestamp":1804204800000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA131944"],"award-info":[{"award-number":["R01 CA131944"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["CA036727"],"award-info":[{"award-number":["CA036727"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA267582"],"award-info":[{"award-number":["R21 CA267582"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA217798"],"award-info":[{"award-number":["P01 CA217798"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA210637"],"award-info":[{"award-number":["R01 CA210637"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX004676-01A1"],"award-info":[{"award-number":["1I01BX004676-01A1"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016764","name":"Fred and Pamela Buffett Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010702","name":"University of Nottingham Malaysia Campus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218333","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:03:10Z","timestamp":1772294590000},"page":"218333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ixazomib triggers autophagic degradation of MUC5AC\/integrin-\u03b24 and inhibits non-small cell lung cancer progression"],"prefix":"10.1016","volume":"645","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-8729","authenticated-orcid":false,"given":"Muthamil Iniyan","family":"Appadurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1795-3598","authenticated-orcid":false,"given":"Zahraa Wajih","family":"Alsafwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashu","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Somavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriman N.","family":"Dooshety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8342-189X","authenticated-orcid":false,"given":"Ben S.","family":"Kubicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-2223","authenticated-orcid":false,"given":"Imayavaramban","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3724-2671","authenticated-orcid":false,"given":"Apar Kishor","family":"Ganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib1","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41467-024-55068-2","article-title":"Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2026.218333_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109742","article-title":"Morphological basis of the lung adenocarcinoma subtypes","volume":"27","author":"Zha","year":"2024","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.canlet.2026.218333_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010674","article-title":"Determinants of 5-year survival in patients with advanced NSCLC with PD-L1\u226550% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry","volume":"13","author":"Cortellini","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2026.218333_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2024.05.002","article-title":"5-Year real-world outcomes with frontline pembrolizumab monotherapy in PD-L1 expression \u2265 50% advanced NSCLC","volume":"25","author":"Velcheti","year":"2024","journal-title":"Clin. Lung Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2026.218333_bib6","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218333_bib7","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.21037\/jtd-24-1078","article-title":"Resistance mechanisms of non-small cell lung cancer and improvement of treatment effects through nanotechnology: a narrative review","volume":"16","author":"Cao","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","article-title":"Advances in molecular pathology and therapy of non-small cell lung cancer","volume":"10","author":"Huang","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12672-025-02076-3","article-title":"PD-1\/PD-L1 blockade therapy with atezolizumab: a new paradigm in the treatment of non-small cell lung cancer (NSCLC)","volume":"16","author":"Moradi","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/acsomega.2c04078","article-title":"Advances in lung cancer treatment using nanomedicines","volume":"8","author":"Sharma","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.canlet.2026.218333_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101229","article-title":"Overcoming cancer therapy resistance: from drug innovation to therapeutics","volume":"81","author":"Wei","year":"2025","journal-title":"Drug Resist. Updates : Revi. Comment. Antimicr. Anticanc. Chemother."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13046-025-03528-y","article-title":"Activating NEDD4L suppresses EGFR-Driven lung adenocarcinoma growth via facilitating EGFR proteasomal degradation","volume":"44","author":"Chen","year":"2025","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"5","key":"10.1016\/j.canlet.2026.218333_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells11050851","article-title":"Ubiquitination-proteasome System (UPS) and autophagy two main protein degradation machineries in response to cell stress","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218333_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1608140","article-title":"The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets","volume":"16","author":"Yuan","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218333_bib16","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/1878-0261.12956","article-title":"ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation","volume":"15","author":"Lakshmanan","year":"2021","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-024-01934-y","article-title":"Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91932-7","article-title":"Autophagy of mucin granules contributes to resolution of airway mucous metaplasia","volume":"11","author":"Sweeter","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib19","article-title":"Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218333_bib20","author":"Joerg Mueller"},{"key":"10.1016\/j.canlet.2026.218333_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"issue":"22","key":"10.1016\/j.canlet.2026.218333_bib22","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1158\/0008-5472.CAN-17-1605","article-title":"Genomic landscape of atypical adenomatous hyperplasia reveals divergent modes to lung adenocarcinoma","volume":"77","author":"Sivakumar","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218333_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40262-018-0702-1","article-title":"Clinical pharmacology of Ixazomib: the first oral proteasome inhibitor","volume":"58","author":"Gupta","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.canlet.2026.218333_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112043","article-title":"Elevated PAF1-RAD52 axis confers chemoresistance to human cancers","volume":"42","author":"Rauth","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218333_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-1-4939-7154-1_30","article-title":"Informatics approaches for predicting, understanding, and testing cancer drug combinations","volume":"1636","author":"Tang","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218333_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.12","article-title":"Overexpression of caspase 7 is ER\u03b1 dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip)","volume":"5","author":"Chaudhary","year":"2016","journal-title":"Oncogenesis"},{"issue":"48","key":"10.1016\/j.canlet.2026.218333_bib27","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1038\/s41388-022-02493-6","article-title":"Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma","volume":"41","author":"Lakshmanan","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13058-023-01630-7","article-title":"MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1\/HUR","volume":"25","author":"Chaudhary","year":"2023","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2026.218333_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186863","article-title":"ST6GalNAc-I regulates tumor cell sialylation via NECTIN2\/MUC5AC-mediated immunosuppression and angiogenesis in non\u2013small cell lung cancer","volume":"135","author":"Appadurai","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"136","key":"10.1016\/j.canlet.2026.218333_bib30","article-title":"Murine oropharyngeal aspiration model of ventilator-associated and hospital-acquired bacterial pneumonia","author":"Nielsen","year":"2018","journal-title":"JoVE J."},{"issue":"23","key":"10.1016\/j.canlet.2026.218333_bib31","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood-2017-10-811620","article-title":"Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice","volume":"131","author":"Ghobadi","year":"2018","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.canlet.2026.218333_bib32","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-16-2530","article-title":"MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53","volume":"23","author":"Lakshmanan","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"W1","key":"10.1016\/j.canlet.2026.218333_bib33","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218333_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.canlet.2026.218333_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094922","article-title":"CD44+ and CD133+ non-small cell lung cancer cells exhibit DNA damage response pathways and dormant polyploid giant cancer cell enrichment relating to their p53 status","volume":"23","author":"Pustovalova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218333_bib36","article-title":"Lung cancer stem cell markers as therapeutic targets: an update on signaling pathways and therapies","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218333_bib37","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1128\/MCB.01830-08","article-title":"H2AX is required for cell cycle arrest via the p53\/p21 pathway","volume":"29","author":"Fragkos","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"23","key":"10.1016\/j.canlet.2026.218333_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315410","article-title":"Revisiting the anti-cancer toxicity of clinically approved platinating derivatives","volume":"23","author":"Forgie","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.canlet.2026.218333_bib39","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1038\/onc.2015.478","article-title":"MUC5AC interactions with integrin \u03b24 enhances the migration of lung cancer cells through FAK signaling","volume":"35","author":"Lakshmanan","year":"2016","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.canlet.2026.218333_bib40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41580-025-00919-z","article-title":"Decoding ubiquitin signals inside cells","volume":"26","author":"Kiss","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-017-00299-9","article-title":"An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.canlet.2026.218333_bib42","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s12276-024-01255-6","article-title":"Dissecting the MUC5AC\/ANXA2 signaling axis: implications for brain metastasis in lung adenocarcinoma","volume":"56","author":"Chaudhary","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"5795","key":"10.1016\/j.canlet.2026.218333_bib43","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science (New York, NY)"},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12859-016-1062-1","article-title":"QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics","volume":"17","author":"O'Reilly","year":"2016","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.canlet.2026.218333_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40265-016-0548-5","article-title":"Ixazomib: first global approval","volume":"76","author":"Shirley","year":"2016","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.canlet.2026.218333_bib46","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3390\/biom15111524","article-title":"Cleaving expectations: a review of proteasome functional and catalytic diversity","volume":"15","author":"Zachor-Movshovitz","year":"2025","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.canlet.2026.218333_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70050","article-title":"Mechanistic insights and therapeutic potentials of ubiquitin-proteasome System in non-small cell lung cancer","volume":"58","author":"Zhou","year":"2025","journal-title":"Cell Prolif."},{"issue":"6","key":"10.1016\/j.canlet.2026.218333_bib48","first-page":"1331","article-title":"PSME3 promotes lung adenocarcinoma development by regulating the TGF-\u03b2\/SMAD signaling pathway","volume":"13","author":"Wang","year":"2024"},{"issue":"10","key":"10.1016\/j.canlet.2026.218333_bib49","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41556-024-01488-7","article-title":"Nuclear proteasomes buffer cytoplasmic proteins during autophagy compromise","volume":"26","author":"Park","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218333_bib50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41418-021-00922-9","article-title":"The role of Ubiquitination in Apoptosis and necroptosis","volume":"29","author":"Roberts","year":"2022","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12943-025-02472-x","article-title":"Targeting proteostasis for cancer therapy: current advances, challenges, and future perspectives","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218333_bib52","article-title":"Knockdown of LMNB1 inhibits the proliferation of lung adenocarcinoma cells by inducing DNA damage and cell senescence","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41419-023-06256-3","article-title":"NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218333_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115943","article-title":"Design and synthesis of the first PARP-1 and proteasome dual inhibitors to treat breast cancer","volume":"264","author":"He","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41418-021-00843-7","article-title":"Proteasome inhibition triggers the formation of TRAIL receptor 2 platforms for caspase-8 activation that accumulate in the cytosol","volume":"29","author":"Hellwig","year":"2022","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.canlet.2026.218333_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119688","article-title":"TRAIL-induced apoptosis and proteasomal activity \u2013 mechanisms, signalling and interplay","volume":"1871","author":"Boccellato","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"23","key":"10.1016\/j.canlet.2026.218333_bib57","article-title":"Unraveling the guardian: p53's multifaceted role in the DNA damage response and tumor treatment strategies","volume":"25","author":"Zhang","year":"2024"},{"issue":"3","key":"10.1016\/j.canlet.2026.218333_bib58","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.molcel.2007.06.013","article-title":"APC\/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase","volume":"27","author":"Amador","year":"2007","journal-title":"Mol. Cell"},{"issue":"Pt 15","key":"10.1016\/j.canlet.2026.218333_bib59","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1242\/jcs.085480","article-title":"MMP9 cleavage of the \u03b24 integrin ectodomain leads to recurrent epithelial erosions in mice","volume":"124","author":"Pal-Ghosh","year":"2011","journal-title":"J. Cell Sci."},{"issue":"23","key":"10.1016\/j.canlet.2026.218333_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239107","article-title":"The crosstalk between FAK and wnt signaling pathways in cancer and its therapeutic implication","volume":"21","author":"W\u00f6rthm\u00fcller","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218333_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215585","article-title":"DGKA interacts with SRC\/FAK to promote the metastasis of non-small cell lung cancer","volume":"532","author":"Fu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218333_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216516","article-title":"SHC4 orchestrates \u03b2-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting Src kinase autophosphorylation","volume":"582","author":"Zhong","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-020-01156-y","article-title":"Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance","volume":"19","author":"Pothuraju","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1-2","key":"10.1016\/j.canlet.2026.218333_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11010-015-2331-4","article-title":"Maclurin suppresses migration and invasion of human non-small-cell lung cancer cells via anti-oxidative activity and inhibition of the Src\/FAK-ERK-\u03b2-catenin pathway","volume":"402","author":"Ku","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2026.218333_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218097","article-title":"Cancer dormancy and metabolism: from molecular insights to translational opportunities","volume":"635","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218333_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218194","article-title":"SRC at the crossroads of KRAS inhibitor resistance: mechanisms and therapeutic opportunities","volume":"639","author":"Tian","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2011.05.008","article-title":"Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780","volume":"309","author":"Sol\u00e1r","year":"2011","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.canlet.2026.218333_bib68","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218333_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108458","article-title":"Integrins in cancer: emerging mechanisms and therapeutic opportunities","volume":"247","author":"Liu","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1134\/S0006297915010113","article-title":"Implication of \u03b12\u03b21 integrin in anoikis of MCF-7 human breast carcinoma cells","volume":"80","author":"Morozevich","year":"2015","journal-title":"Biochemistry Biokhimiia"},{"issue":"2","key":"10.1016\/j.canlet.2026.218333_bib71","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1878-0261.12845","article-title":"Constitutive activation of integrin \u03b1v\u03b23 contributes to anoikis resistance of ovarian cancer cells","volume":"15","author":"Dolinschek","year":"2021","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218333_bib72","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK\u2013Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218333_bib73","article-title":"Combined inhibition of focal adhesion kinase and RAF\/MEK elicits synergistic inhibition of melanoma growth and reduces metastases","volume":"6","author":"Almazan","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"5","key":"10.1016\/j.canlet.2026.218333_bib74","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/carcin\/bgy019","article-title":"Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view","volume":"39","author":"Krishn","year":"2018","journal-title":"Carcinogenesis"},{"issue":"15","key":"10.1016\/j.canlet.2026.218333_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120941","article-title":"Requirement for MUC5AC in KRAS-dependent lung carcinogenesis","volume":"3","author":"Bauer","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.canlet.2026.218333_bib76","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jjco\/hyaa016","article-title":"MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis","volume":"50","author":"Dong","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218333_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217909","article-title":"Autophagy paradox: genetic and epigenetic control of autophagy in cancer progression","volume":"630","author":"Bhol","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218333_bib79","first-page":"1","article-title":"Aggregate fragmentation: the ticket to aggrephagy","author":"Mauthe","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218333_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107455","article-title":"Bortezomib modulated the autophagy-lysosomal pathway in a TFEB-dependent manner in multiple myeloma","volume":"138","author":"Zhang","year":"2024","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41419-022-04508-2","article-title":"Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer","volume":"13","author":"Bi","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91932-7","article-title":"Autophagy of mucin granules contributes to resolution of airway mucous metaplasia","volume":"11","author":"Sweeter","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218333_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217285","article-title":"Autophagy and cancer therapy","volume":"605","author":"Pimentel","year":"2024","journal-title":"Cancer Lett."},{"issue":"42","key":"10.1016\/j.canlet.2026.218333_bib84","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2406936121","article-title":"TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer","volume":"121","author":"Ye","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.canlet.2026.218333_bib85","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184665","article-title":"Ubiquitin-conjugating enzyme UBE2N modulates proteostasis in immunoproteasome-positive acute myeloid leukemia","volume":"135","author":"Ishikawa","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.canlet.2026.218333_bib86","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2026.218333_bib87","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-19-1373","article-title":"Deubiquitinase activity profiling identifies UCHL1 as a candidate oncoprotein that promotes TGF\u03b2-Induced breast cancer metastasis","volume":"26","author":"Liu","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218333_bib88","article-title":"UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:20:25Z","timestamp":1778538025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":87,"alternative-id":["S0304383526000960"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218333","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ixazomib triggers autophagic degradation of MUC5AC\/integrin-\u03b24 and inhibits non-small cell lung cancer progression","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218333"}}